CVS Health has delivered four consecutive earnings beats with an average positive surprise near 17% and converts net income to free cash flow at a ratio of roughly 1.8 times. However, the stock has reached its near-term price target with zero headroom remaining and a reward-to-risk ratio at essentially zero, overall quality sits below the minimum threshold at 3.3 out of 10, and an active legal risk event has triggered a gate failure alongside a dividend safety warning.
Thesis pillars
- Quality Below Minimum Floor↓Deteriorating
- Consistent Earnings Outperformance↑Improving
- Strong Free Cash Flow Conversion→Stable
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 10, 2026· older than 90 days
CVS Health Corporation (CVS) Stock Analysis
Oversold Bounce setup
Healthcare · Healthcare Plans
Sell if holding. Engine safety override at $79.96: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.0/10 and A.R:R 4.0:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality; Negative price momentum; Below long-term trend.
CVS Health operates approximately 9,000 retail pharmacies, 1,000+ medical clinics, a PBM serving ~87 million plan members, and Aetna insurance serving ~37 million members across four segments. Revenue comes from pharmacy dispensing, PBM service fees, and health insurance... Read more
Sell if holding. Engine safety override at $79.96: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.0/10 and A.R:R 4.0:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality; Negative price momentum; Below long-term trend. Chart setup: Oversold RSI 28, near Bollinger lower, volume surge. Score 6.0/10, moderate confidence.
Passes 5/7 gates (favorable risk/reward ratio, clean insider activity, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum. Suitability: moderate.
Recent developments
updated Nov 5, 2026Recent Developments — CVS Health Corporation
Latest news
- NEWS Elizabeth Warren Says CVS Is Still Trying To ‘Rip People Off’ With Planned Breakup as Mark Cuban Says Split ‘Changes Not — benzinga Nov 5, 2026 negative
- NEWS CVS Health Raises Its Outlook, Confirms Massive Breakup — benzinga Nov 4, 2026 positive
- NEWS CVS Health Q3 2026 Earnings Call Transcript — benzinga Nov 4, 2026 neutral
- NEWS CVS Health Exec Says Expects Margin Improvements In Its Healthcare Benefits Business In 2027; Expects To Deliver At Leas — benzinga Nov 4, 2026 positive
- NEWS CVS Health Announces Plan to Separate into Two Independent Companies — fiscal.ai Nov 4, 2026 neutral
Latest item Nov 5, 2026 · Generated 2026-11-05T11:39:29Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- LOWCustomerU.S. federal government20%10-K Item 1: 'Health Care Benefits segment revenues from the federal government accounted for approximately 20% of the Company's consolidated total revenues in 2025'
Material Events(8-K, last 90d)
- 2026-05-18Item 5.02LOWCVS Health 2026 Annual Meeting (May 14, 2026): stockholders approved the 2026 Incentive Compensation Plan, replacing the expiring 2017 plan. No officer departures or director elections reported in this item.SEC filing →
- 2026-03-19Item 5.02LOWBoard elected John E. Gallina (former CFO of Elevance Health) as director, effective March 19, 2026. Routine board addition; no officer departure cited.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers·1 ceiling hit
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Quality below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $79.96: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.0/10 and A.R:R 4.0:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality; Negative price momentum; Below long-term trend. Chart setup: Oversold RSI 28, near Bollinger lower, volume surge. Prior stop was $75.01. Score 6.0/10, moderate confidence.
Analyst target: $103.97 (+30.0% upside). Prior stop was $75.01. Stop-loss: $75.01.
Quality below floor (3.4 < 4.0).
CVS Health Corporation trades at a P/E of 9.3 (forward 9.4). TrendMatrix value score: 8.9/10. Verdict: Sell.
32 analysts rate CVS, with a consensus score of 4.1/5. 25 analysts publish price targets averaging $116.
What does CVS Health Corporation do?CVS Health operates approximately 9,000 retail pharmacies, 1,000+ medical clinics, a PBM serving ~87 million plan...
CVS Health operates approximately 9,000 retail pharmacies, 1,000+ medical clinics, a PBM serving ~87 million plan members, and Aetna insurance serving ~37 million members across four segments. Revenue comes from pharmacy dispensing, PBM service fees, and health insurance premiums; federal government programs represented ~20% of consolidated 2025 revenues.